Bosnalijek Brings Together International Medical Experts at Lysobact Advisory Board

Yesterday, Bosnalijek hosted the international expert meeting Lysobact Advisory Board in Sarajevo, bringing together distinguished professors, physicians, and medical experts from numerous countries to exchange knowledge, experience, and professional perspectives in the fields of infectious diseases, paediatrics, and otorhinolaryngology.


 Bosnalijek Brings Together International Medical Experts at Lysobact Advisory Board

The meeting provided an important opportunity for international dialogue and discussion of current clinical practices, as well as for sharing experiences regarding opportunities for further development and improvement of healthcare. Participants included experts from Bosnia and Herzegovina, the Russian Federation, Serbia, Croatia, Libya, Georgia, Kosovo, Ukraine, Moldova, Albania, Türkiye, North Macedonia and Montenegro.

The programme featured a series of expert presentations and discussions, during which various professional and clinical experiences in the treatment of upper respiratory tract diseases in the fields of infectious diseases, paediatrics and otorhinolaryngology were presented. Particular attention was paid to the importance of modern therapeutic approaches, the exchange of scientific knowledge, and fostering connections among experts from different healthcare systems.

The meeting also addressed the significance of Lysobact on the pharmaceutical market. Years of experience and trust are an important part of the product's recognition among generations of healthcare professionals and patients.

Professor Aleksandr Vasilievich Gorelov, Academician of the Russian Academy of Sciences and Deputy Director for Science at the Central Research Institute of Epidemiology in Moscow, also spoke about the importance of the product's longstanding presence on the market, stating:

"Lysobact is the gold standard among topical antiseptics. Its longstanding presence on the pharmaceutical market is a testament to its high efficacy and proven safety profile, established over time and confirmed through clinical practice.”

Professor Elena Petrovna Karpova, a paediatrician and paediatric otorhinolaryngologist from Moscow, spoke about the trust in Lysobact shared across generations:

"Lysobact represents a bond between generations. Our grandmothers used it to relieve throat discomfort, and today we entrust it with what is most precious to us – the health of our children.”

One of the key programme highlights was the presentation of the publication Lysobact Medical Evidence Book of Abstracts, which contributes to the documentation of medical evidence regarding the efficacy and safety of medicines and other preparations containing lysozyme.

The meeting also highlighted the role of lysozyme in addressing the global problem of bacterial resistance to antibiotics.

By organising this international meeting, Bosnalijek continues to develop cooperation with medical experts and the scientific community, creating opportunities for open dialogue, the exchange of experience and networking among experts from different countries.

Such gatherings contribute to a better understanding of current medical needs and expectations and represent an important part of the company's ongoing commitment to improving the quality of healthcare.







November 20, 2026
Previous news
Bosnalijek Brings Together International Medical Experts at Lysobact Ad ... LYSOBACT Advisory Board Bosnalijek and the Faculty of Pharmacy of the University of Sarajevo Joi ... Public notice The Conference exceeded the expectations of the attendees Bosnalijek winner of the Award for Business Leaders of Sustainable Devel ... Danish journalists were convinced of the top quality of Bosnalijek Cooperation Agreement Signed between Bosnalijek and Abdi Ibrahim – Bosna ... Bosnalijek breaks its own business records Record semi-annual performance of Bosnalijek in 2022
novembar 20. 2026 |
SASE |
BSNLR - Bosnalijek d.d. Sarajevo: 12,47 3,89%
```html